April 9, 2022

Study finds potential association between allostatic load and worse overall survival in multiple myeloma

April 9, 2022

Mixed quality of life findings following treatment highlight need for breast cancer support services

April 7, 2022

African ancestry, high BMI predictive of worse breast cancer outcomes

March 25, 2022

Enrollment in TMIST breast cancer screening trial surpasses halfway mark; Black participation rises above 20%

March 8, 2022

JAMA Oncology publishes TAILORx data showing racial and neighborhood disparities in breast cancer

February 28, 2022

Dr. Edith Mitchell discusses ECOG-ACRIN’s work to improve representation of minority populations in cancer clinical trials

November 12, 2021

NCTN group chairs, experts: Diverse representation of minorities in clinical trials and drug development saves lives

November 3, 2021

The role of allostatic load in breast cancer treatment and survival

November 1, 2021

Dr. Stephanie Patterson speaks about the TMIST breast cancer screening trial

ECOG-ACRIN Cancer Research Group